Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Medicure (MCUJF) over the last 13 years, with Q3 2025 value amounting to -$74098.4.

  • Medicure's Cash from Financing Activities fell 2033.56% to -$74098.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$303579.4, marking a year-over-year decrease of 2827.32%. This contributed to the annual value of -$264864.2 for FY2024, which is 2140.99% down from last year.
  • Latest data reveals that Medicure reported Cash from Financing Activities of -$74098.4 as of Q3 2025, which was down 2033.56% from -$81553.5 recorded in Q2 2025.
  • In the past 5 years, Medicure's Cash from Financing Activities ranged from a high of $511708.6 in Q2 2021 and a low of -$916748.4 during Q3 2021
  • Its 5-year average for Cash from Financing Activities is -$72041.5, with a median of -$62197.1 in 2022.
  • Per our database at Business Quant, Medicure's Cash from Financing Activities surged by 14951.62% in 2021 and then tumbled by 12345.17% in 2022.
  • Quarter analysis of 5 years shows Medicure's Cash from Financing Activities stood at $232447.5 in 2021, then tumbled by 172.24% to -$167917.4 in 2022, then skyrocketed by 68.5% to -$52886.6 in 2023, then plummeted by 62.43% to -$85901.9 in 2024, then grew by 13.74% to -$74098.4 in 2025.
  • Its Cash from Financing Activities was -$74098.4 in Q3 2025, compared to -$81553.5 in Q2 2025 and -$62025.6 in Q1 2025.